153 related articles for article (PubMed ID: 17152012)
1. Ferrophilic characteristics of Vibrio vulnificus and potential usefulness of iron chelation therapy.
Kim CM; Park RY; Choi MH; Sun HY; Shin SH
J Infect Dis; 2007 Jan; 195(1):90-8. PubMed ID: 17152012
[TBL] [Abstract][Full Text] [Related]
2. Effect of the crp mutation on the utilization of transferrin-bound iron by Vibrio vulnificus.
Choi MH; Sun HY; Park RY; Kim CM; Bai YH; Kim YR; Rhee JH; Shin SH
FEMS Microbiol Lett; 2006 Apr; 257(2):285-92. PubMed ID: 16553865
[TBL] [Abstract][Full Text] [Related]
3. A widespread deferoxamine-mediated iron-uptake system in Vibrio vulnificus.
Kim CM; Park YJ; Shin SH
J Infect Dis; 2007 Nov; 196(10):1537-45. PubMed ID: 18008234
[TBL] [Abstract][Full Text] [Related]
4. Vibrio vulnificus metalloprotease VvpE has no direct effect on iron-uptake from human hemoglobin.
Sun HY; Han SI; Choi MH; Kim SJ; Kim CM; Shin SH
J Microbiol; 2006 Oct; 44(5):537-47. PubMed ID: 17082748
[TBL] [Abstract][Full Text] [Related]
5. Role of periplasmic binding proteins, FatB and VatD, in the vulnibactin utilization system of Vibrio vulnificus M2799.
Kawano H; Miyamoto K; Sakaguchi I; Myojin T; Moriwaki M; Tsuchiya T; Tanabe T; Yamamoto S; Tsujibo H
Microb Pathog; 2013 Dec; 65():73-81. PubMed ID: 24135791
[TBL] [Abstract][Full Text] [Related]
6. Iron differentially regulates gene expression and extracellular secretion of Vibrio vulnificus cytolysin-hemolysin.
Kim CM; Chung YY; Shin SH
J Infect Dis; 2009 Aug; 200(4):582-9. PubMed ID: 19586415
[TBL] [Abstract][Full Text] [Related]
7. Vibrio vulnificus metalloprotease VvpE has no direct effect on the iron-assimilation from human holotransferrin.
Shin SH; Sun HY; Park RY; Kim CM; Kim SY; Rhee JH
FEMS Microbiol Lett; 2005 Jun; 247(2):221-9. PubMed ID: 15936899
[TBL] [Abstract][Full Text] [Related]
8. Involvement of vulnibactin and exocellular protease in utilization of transferrin- and lactoferrin-bound iron by Vibrio vulnificus.
Okujo N; Akiyama T; Miyoshi S; Shinoda S; Yamamoto S
Microbiol Immunol; 1996; 40(8):595-8. PubMed ID: 8887355
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the effects of deferasirox, deferiprone, and deferoxamine on the growth and virulence of Vibrio vulnificus.
Neupane GP; Kim DM
Transfusion; 2009 Aug; 49(8):1762-9. PubMed ID: 19413741
[TBL] [Abstract][Full Text] [Related]
10. IutB participates in the ferric-vulnibactin utilization system in Vibrio vulnificus M2799.
Kawano H; Miyamoto K; Negoro M; Zushi E; Tsuchiya T; Tanabe T; Funahashi T; Tsujibo H
Biometals; 2017 Apr; 30(2):203-216. PubMed ID: 28150143
[TBL] [Abstract][Full Text] [Related]
11. Non-transferrin-bound iron in platelet concentrates promotes the growth of Staphylococcus epidermidis.
Matinaho S; Parkkinen J
Transfusion; 2005 Jun; 45(6):927-33. PubMed ID: 15934991
[TBL] [Abstract][Full Text] [Related]
12. Use of a marker plasmid to examine differential rates of growth and death between clinical and environmental strains of Vibrio vulnificus in experimentally infected mice.
Starks AM; Bourdage KL; Thiaville PC; Gulig PA
Mol Microbiol; 2006 Jul; 61(2):310-23. PubMed ID: 16856938
[TBL] [Abstract][Full Text] [Related]
13. Nonribosomal peptide synthase is responsible for the biosynthesis of siderophore in Vibrio vulnificus MO6-24/O.
Kim IH; Shim JI; Lee KE; Hwang W; Kim IJ; Choi SH; Kim KS
J Microbiol Biotechnol; 2008 Jan; 18(1):35-42. PubMed ID: 18239413
[TBL] [Abstract][Full Text] [Related]
14. Proteomic analysis of Vibrio vulnificus M2799 grown under iron-repleted and iron-depleted conditions.
Miyamoto K; Kosakai K; Ikebayashi S; Tsuchiya T; Yamamoto S; Tsujibo H
Microb Pathog; 2009 Mar; 46(3):171-7. PubMed ID: 19185608
[TBL] [Abstract][Full Text] [Related]
15. The RND protein is involved in the vulnibactin export system in Vibrio vulnificus M2799.
Kawano H; Miyamoto K; Yasunobe M; Murata M; Myojin T; Tsuchiya T; Tanabe T; Funahashi T; Sato T; Azuma T; Mino Y; Tsujibo H
Microb Pathog; 2014 Oct; 75():59-67. PubMed ID: 25205089
[TBL] [Abstract][Full Text] [Related]
16. Vibrio vulnificus vulnibactin, but not metalloprotease VvpE, is essentially required for iron-uptake from human holotransferrin.
Kim CM; Park RY; Park JH; Sun HY; Bai YH; Ryu PY; Kim SY; Rhee JH; Shin SH
Biol Pharm Bull; 2006 May; 29(5):911-8. PubMed ID: 16651718
[TBL] [Abstract][Full Text] [Related]
17. Monitoring the efficiency of iron chelation therapy: the potential of nontransferrin-bound iron.
Hider RC; Silva AM; Podinovskaia M; Ma Y
Ann N Y Acad Sci; 2010 Aug; 1202():94-9. PubMed ID: 20712779
[TBL] [Abstract][Full Text] [Related]
18. Chelator-facilitated removal of iron from transferrin: relevance to combined chelation therapy.
Devanur LD; Evans RW; Evans PJ; Hider RC
Biochem J; 2008 Jan; 409(2):439-47. PubMed ID: 17919118
[TBL] [Abstract][Full Text] [Related]
19. Bicarbonate inhibits the growth of Staphylococcus epidermidis in platelet concentrates by lowering the level of non-transferrin-bound iron.
Matinaho S; Karhumäki P; Parkkinen J
Transfusion; 2005 Nov; 45(11):1768-73. PubMed ID: 16271102
[TBL] [Abstract][Full Text] [Related]
20. Influence of iron-chelated growth conditions on outer membrane protein production and virulence of Vibrio tubiashii.
Jean-Gilles Beaubrun J; Gopinath G; Kothary MH; Franco A; Curtis SK; Eribo BE; Tall BD
Food Microbiol; 2011 Oct; 28(7):1409-13. PubMed ID: 21839393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
